Guidance adored to reduce effects of LED street lighting
Andrea Fisher discusses LED roadway lighting energy savings and glare issues from blue rich light. She notes AMA guidance to minimize blue emission, shielded fixtures, and possible yellow filters, with optometry input on circadian effects and visual comfort.
MENTIONED IN THIS ARTICLE
U.S
United States
Lorain
American Medical Association
AMA
The
Ing
FDA approves lifitegraft as new dry eye therapy
The FDA approves lifitegraft ophthalmic solution from Shire as a first in class LFA-1 inhibitor to treat dry eye signs and symptoms. It blocks LFA-1 to ICAM-1 interaction, reducing T cell activation and inflammatory cascades on the ocular surface. Restasis remains a cyclosporine emulsion with a different mechanism and longer onset. Insurance coverage may be limited at launch in Q3 2016. Andrea Fisher of North Coast Eye Care in Amherst is noted with contact details.
MENTIONED IN THIS ARTICLE
Andrea Fisher
North Coast Eye Care
Cooper Foster Park Road
Amherst
Fisher
Food and Drug Administration
Shire
Lifitegraft
U.S
Wwe
Com
Also Mentioned on This Page
Andrea L. Fisher
the Chronicle
Metro Creative
FDA
North Coast
Cooper Foster Park
AVON
Chester Road
N. Ridgeville
Center Ridge Road
Northcoasteyecare.com
Vermilion
Liberty Avenue
Miele